Novartis invests $100 mn to eliminate malaria
Novartis is to invest more than $ 100 million to advance research and development of new antimalarials over the next five years...
List view / Grid view
News
FDA accepts NDA for ALKS 5461 for major depressive disorder
The FDA has accepted for review the New Drug Application for ALKS 5461, a novel, once-daily, oral investigational medicine for the adjunctive treatment of major depressive disorder ...
Painkillers in pregnancy may affect baby’s future fertility
Taking painkillers during pregnancy could affect the fertility of the unborn child in later life, research suggests...
Contrast-enhanced subharmonic imaging detects prostate cancers
A test of contrast-enhanced subharmonic imaging has shown promise in detecting prostate cancers that were not identified by MRI...
Naloxone promotes stroke recovery in rats
Life-saving opioid overdose drug may benefit stroke patients...
Nivolumab reduces size of some lung cancer tumours, relapse rate after surgery
A drug given to early-stage lung cancer patients before they undergo surgery showed major tumour responses in the removed tumour...
Iron supplements may influence the development of colon cancer
Two common iron compounds increase the formation of a known biomarker for cancer...
FDA permits marketing of AI-based device to detect diabetic retinopathy
The FDA has permitted marketing of the first medical device to use artificial intelligence to detect greater than a mild level of the eye disease diabetic retinopathy...
Vaccine suppresses peanut allergies in mice
Researchers aim to develop a new immunotherapy that could alter the immune reactions to food. The result: Extended relief from peanut allergies...
First-in-Human trial of cannabis-based therapy for Parkinson’s initiated
GB Sciences, Inc. is planning to file an Exploratory IND and perform a Phase 0 Clinical Trial to gather valuable First-In-Human data on its proprietary cannabis-based therapies...
Second patent awarded for AdvantaPure®’s AdvantaPass® clean room wall pass-through system
Significant Improvements Prompt Issuance...
Injectable sensor could provide unobtrusive, long-term alcohol monitoring
Engineers have developed a miniature, ultra-low power injectable biosensor that could be used for continuous, long-term alcohol monitoring...
Simultaneous chemo and immunotherapy is effective in metastatic bladder cancer
Researchers have discovered that giving metastatic bladder cancer patients simultaneous chemotherapy and immunotherapy is safe and that patients whose tumours have certain genetic mutations...
Bruker launches new FT-IR R&D Spectrometer INVENIO™
Bruker today announces the launch of the new INVENIO™ Fourier Transform Infrared (FT-IR) research spectrometer. The INVENIO is the successor to the renowned VERTEX 70 FT-IR for advanced R&D applications...
Bruker introduces the new CTX™ Portable XRF Analyzer
Bruker today introduces the new CTX™ X-ray fluorescence (XRF) elemental analyzer. The portable Counter Top XRF (CTX) is small, light-weight, safety-interlocked, and battery operated. At less than 7 kilograms in weight, the self-contained CTX is truly portable, and has a small footprint of 14 cm in width...
